InVitae competitors

InVitae's competitors include Clementia Pharmaceuticals, Innate Pharma, Synthace and DBV Technologies
Add company...
InVitae
InVitae provides genetic diagnostics for hereditary disorders.
Clementia Pharmaceuticals
Clementia Pharmaceuticals develops and commercializes therapeutics for people suffering from rare diseases.
Innate Pharma
Innate Pharma S.A. is a clinical-stage biotechnology company with a focus on discovering and developing first-in-class therapeutic antibodies that harness the innate immune system to improve cancer treatment and clinical outcomes for patients.
Synthace
Synthace produces bio-based chemical products through the application of synthetic biology.
DBV Technologies
We are committed to finding a safe, effective and patient-friendly therapy for food and pediatric allergy patients, for whom there are no currently approved treatments.
Founding Date
Founding Date
2010
Founding Date
2012
Founding Date
1999
Founding Date
2011
Founding Date
2002
Type
Type
Public
Type
Private
Type
Public
Type
Private
Type
Public
Tags
Locations
Locations
San Francisco, US HQ
Locations
Westmount, CA HQ
Newton, US
Locations
Marseille, FR HQ
Locations
London, GB HQ
Locations
Montrouge, FR HQ
New York, US
Employees
Employees
50940% increase
Employees
422% increase
Employees
127
Employees
425% increase
Employees
113
Valuation ($)
Valuation ($)
543.7 m
Valuation ($)
N/A
Valuation ($)
588.7 m
Valuation ($)
N/A
Valuation ($)
1.1 b
Facebook likes
Facebook likes
23.5 k
Facebook likes
N/A
Facebook likes
N/A
Facebook likes
66
Facebook likes
2.6 k
Twitter followers
Twitter followers
5.3 k
Twitter followers
N/A
Twitter followers
2 k
Twitter followers
506
Twitter followers
814

Financial

Revenue (est.)
Revenue (est.)
$68.2m (FY, 2017)
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
£581 (FY, 2013)
Revenue (est.)
N/A
Net income
Net income
($123.4m) (FY, 2017)
Net income
($57.5m) (FY, 2016)
Net income
N/A
Net income
(£361.6k) (FY, 2013)
Net income
N/A

Funding

Latest funding round
Latest funding round
N/A
Latest funding round
$ 60m (almost 3 years ago)
Latest funding round
N/A
Latest funding round
$ 9.9m (9 months ago)
Latest funding round
N/A
Total funding raised
Total funding raised
$ 195.5m
Total funding raised
$ 92.5m
Total funding raised
$ 94.1m
Total funding raised
$ 16.2m
Total funding raised
$ 28.2m
For sources of this data, please see the company profileDownload Excel

View company profiles

Clementia Pharmaceuticals
HQ
Westmount, CA
Employees
42↑ 2% increase

Clementia Pharmaceuticals develops and commercializes therapeutics for people suffering from rare diseases.

View company
Innate Pharma
HQ
Marseille, FR
Employees
127

Innate Pharma S.A. is a clinical-stage biotechnology company with a focus on discovering and developing first-in-class therapeutic antibodies that harness the innate immune system to improve cancer treatment and clinical outcomes for patients.

View company
Synthace
HQ
London, GB
Employees
42↑ 5% increase

Synthace produces bio-based chemical products through the application of synthetic biology.

View company
DBV Technologies
HQ
Montrouge, FR
Employees
113

We are committed to finding a safe, effective and patient-friendly therapy for food and pediatric allergy patients, for whom there are no currently approved treatments.

View company